type full_text Clinical Summary 81 FNKDAbADLi home amb WSStays with [REDACTED] and daughter in [REDACTED] PMHx 1. AF on apixaban Echo (Feb 2021): Normal LVEF, High probablity of PHT PASP 51 mmHg 2. Dementia on f/u with CGH PSY 3. HTN 4. HLD 5. Non DM nephropathy HbA1c (Feb 21) 5.9 6. Osteoporosis 7. ThalassemiaLast d/c 3 14 Aug 211. Unwitnessed fall b/g recurrent falls, currently on apixaban for AF Apixaban discontinued on 10/8/21 after discussion with family ivo high falls riskComplicated by (a) Right parietal scalp wound with haematoma s/p T S in ED on 3/8/21 For STO on 10/8/21 (b) Mild hypercalcemia (resolved) cCa 2.48 (on adm) > 2.35 2. Fever with no obvious source 3. Incidental finding of stable small ?meningioma 4. Discharge planning Current admission noted history from son in EDAdm for SOB and worsening LL swelling todayPt's [REDACTED] [REDACTED] he prepares her meds in AM and left it out for herPt cannot rmb taking her meds todays/b Dr [REDACTED] [REDACTED] [REDACTED][REDACTED] speak EnglishSaid she came in for SOBDenied fever, cough at homeNot sure if she was taking her meds at homeCorrob history from son:1. LL swelling and effort intolerance since last admission pt's [REDACTED] [REDACTED] initially main concern was LL swelling on day of discharge last Sat, claimed brought up concern re LL swelling but prev team said it's ok subsequently noted pt more SOB mainly SOB after walking few steps unsure re baseline effort tolerance as pt mostly homebound, but generally able to walk at least to toilet/living room without SOB no chest pain, orthopnoea no fever, cough, URTI sx pt did not c/o palpitations on and off pt waking up at night but did not c/o PNDRe medication compliance: [REDACTED] [REDACTED] he is home on weekend hence on discharge, initially pt did not miss meds on Sat, Sunday, he supervised pt's meds and she took it on Monday prior to admission, checked pt's pillbox and noticed pt did not take AM meds hence pt only missed her meds today O/E T 37.3 BP 125/72 HR 135 SpO 2 Paras in ward: manual HR 100 exactlyBP 136/62 SpO2 100 2 L NPAlert, comfortableOriented to place and time but not personLungs: bibasal creps till midzoneAbdomen: soft, non tenderH S 1 S 2 irreg irreg slight tachy Calves supple, pitting edema till midshin In ED Given bisoprolol 3.75 mg oncegiven IV lasix 20 mg once Issues and progress 1. Fast AF ppt by ?non compliance to rate control however according to son, pt only missed one dose of bisoprolol rate 130 s in ED > biso 3.75 mg at 1330 pm > 100 s OA to GW TFT 3/8 normal electrolytes normal, inflamm markers only min raisedComplicated by:a) Fluid overload proBNP 4731 CXR bilat ?atelectasis baseline lasix 20 mg OM since Nov 2020 last TTE in Feb 21 EF 65 no RWMA, but impaired LV diastolic function given IV lasix 40 mg BD on admission alb 452. Mild hyperCa 2' possible primary hyperparathyroidism also noted last admission cCa 2.52 this admission iPTH elevated, not for further workup ivo advanced age. To continue alendronate for now as patient has osteoporosis. Memo to OPS to consider END referral in the future if corrected Ca increases to >2.9 Reviewed by PT while inpatient, cleared for home but recommended day rehab. Son declined day rehabilitationPatient keen for dischargeDischarge / return advice givenPatient discharged well and stable to home on 21/8/2021 Medication changes Increased bisoprolol to 5 mg BDStarted digoxin 62.5 mcg OMStopped calcium supplements in view of hyperCaSuspended losartan in view of raised Cr, well controlled BP Discharge plans 2 nd COVID vaccine date obtained on 14/9, AM slotTCU OPS x 1/52 to follow up on fluid status, RP, HR (digoxin), calcium, BP, KIV restart losartan Memo OPS on discharge possible primary hyperparathyroidism to continue alendronate for now as patient has osteoporosis to consider END referral in the future if corrected Ca increases to >2.9 Care Plan Medication changes Increased bisoprolol to 5 mg BDStarted digoxin 62.5 mcg OMStopped calcium supplements in view of hyperCaSuspended losartan in view of raised Cr, well controlled BP Discharge plans 2 nd COVID vaccine date obtained on 14/9, AM slotTCU OPS x 1/52 to follow up on fluid status, RP, HR (digoxin), calcium, BP, KIV restart losartan Memo OPS on discharge possible primary hyperparathyroidism to continue alendronate for now as patient has osteoporosis to consider END referral in the future if corrected Ca increases to >2.9